Logo
G

Gentronix, Part of Scantox Group

68 employees

Gentronix is a part of Scantox Group. Gentronix is a specialist CRO focused on delivering predictive toxicology products & services to global chemical sectors. Working with companies from early screening through to regulatory safety assessment, we deliver innovative solutions for both genetic toxicology and skin sensitisation. For 20 years, Gentronix Ltd has provided predictive toxicology solutions to global chemical industries; enabling our clients to optimise their development programmes via early identification of genotoxic hazard and assessment of chemical safety. Gentronix offers a comprehensive portfolio of screening and regulatory genotoxicity products & services, along with assessment of skin sensitisation potential.

Investor insights

Funding rounds participated in

$939K sweet spot round size

Investor type

Privately Held

Basic info

Industry

Research Services

Sectors

Research Services

Date founded

1999

Funding rounds raised

Total raised

$939K

from 1 investors over 1 rounds

G

Gentronix, Part of Scantox Group raised $939K on December 15, 2021

Investors: Mercia Fund Managers

FAQ